Healthy lifestyles and the incidence risk and time of carotid plaque: a nationwide cohort study
- PMID: 40665269
- PMCID: PMC12261818
- DOI: 10.1186/s12889-025-23694-0
Healthy lifestyles and the incidence risk and time of carotid plaque: a nationwide cohort study
Abstract
Background: The association between lifestyles and carotid plaque showed heterogeneity in results across studies, which may be limited by sample size or population characteristics. In addition, there is a lack of evidence on how long healthy lifestyles delay plaque development and on the metabolic factors which are likely to mediate these associations. This study aims to investigate the impact of multiple healthy lifestyles on the risk and time of carotid plaque incidence in the early stages of atherosclerotic cardiovascular disease (CVD), and to identify the metabolic factors mediating this association.
Methods: We analyzed data from 43,651 participants with moderate or high risk for CVD from the ChinaHEART cohort (2014-2021), excluding those with prior carotid plaque or CVD, or incomplete data. We examined the association between non-smoking, moderate alcohol intake, sufficient leisure time physical activity (LTPA), and a healthy diet and incident carotid plaque using odds ratios (ORs) and time ratios (TRs) from repeated carotid ultrasounds, and calculated the mediation effects of metabolic factors.
Results: During a mean follow-up period of 1.74 ± 0.43 years, the study included 43,651 participants with a mean age of 57.76 years; 62.5% were female. Incident carotid plaque was documented in 14,698 participants (33.7%). Non-smoking (OR: 0.86 [0.80, 0.91]), moderate alcohol use (0.90 [0.84, 0.97]), sufficient LTPA (0.94 [0.90, 0.99]), and a healthy diet (0.90 [0.84, 0.97]) each independently lowered the risk of carotid plaque, with TRs indicating delays in plaque onset (1.01 to 1.06). Compliance with all four healthy lifestyles significantly reduced plaque risk (OR: 0.64) and delayed onset (TR: 1.16), with stronger effects in the high-risk group (P < 0.05). Metabolic factors varied in their mediation of lifestyle effects on plaque incidence.
Conclusions: Healthy lifestyles are associated with a lower risk and later onset of carotid plaque, suggesting that a primary prevention strategy focusing on multiple healthy behaviors, especially in high-risk individuals, may provide significant benefits.
Keywords: Atherosclerosis; Carotid plaque; China; Health promotion; Healthy lifestyles.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The research reported in this manuscript was conducted in accordance with the Declaration of Helsinki. Approval was obtained from the central ethics committee at Fuwai Hospital, Beijing, China (Approval No. 2014–574). All enrolled participants provided written informed consent. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Nutritional interventions for survivors of childhood cancer.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2. Cochrane Database Syst Rev. 2016. PMID: 27545902 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.Cochrane Database Syst Rev. 2021 Oct 25;10(10):CD013650. doi: 10.1002/14651858.CD013650.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693515 Free PMC article.
References
-
- Joh JH, Cho S. Cardiovascular risk of carotid atherosclerosis: global consensus beyond societal guidelines. Lancet Glob Health. 2020;8(5):e625–6. - PubMed
-
- GBD Results. https://vizhub.healthdata.org/gbd-results/. Accessed 8 July 2025.
-
- Saba L, Saam T, Jäger HR, Yuan C, Hatsukami TS, Saloner D, et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18(6):559–72. - PubMed
-
- Sillesen H, Sartori S, Sandholt B, Baber U, Mehran R, Fuster V. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018;19(9):1042–50. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical